2019
DOI: 10.1016/j.radcr.2018.10.028
|View full text |Cite
|
Sign up to set email alerts
|

Parosteal osteosarcoma with focal fatty metaplasia: A case report

Abstract: Parosteal osteosarcoma originates on the surface of long bones. The juxtacortical variety is one of the most common ones and accounts for about 5% of all osteosarcomas. We report the case of a 34-year-old female patient with a rare variant of parosteal osteosarcoma. Because of the less aggressive biological behavior, it is important to know it, in order to recognize and differentiate it from benign osseous lesions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 8 publications
0
1
0
Order By: Relevance
“…Liposarcomas of bone (also titled osteoliposarcomas or malignant mesenchymomas) were initially reported in 1934 [10]. They are quite rare, most are reported to be pleomorphic and as far as they have been analyzed they were reported MDM2 and CDK4 negative [11,12]. Liposarcomas with osteogenic differentiation are well known and fall in the category of dedifferentiated liposarcoma, the two most common forms of heterologous differentiation in dedifferentiated liposarcoma are myogenic and osteosarcomatous/chondrosarcomatous [13], they show MDM2 amplification.…”
Section: Discussionmentioning
confidence: 99%
“…Liposarcomas of bone (also titled osteoliposarcomas or malignant mesenchymomas) were initially reported in 1934 [10]. They are quite rare, most are reported to be pleomorphic and as far as they have been analyzed they were reported MDM2 and CDK4 negative [11,12]. Liposarcomas with osteogenic differentiation are well known and fall in the category of dedifferentiated liposarcoma, the two most common forms of heterologous differentiation in dedifferentiated liposarcoma are myogenic and osteosarcomatous/chondrosarcomatous [13], they show MDM2 amplification.…”
Section: Discussionmentioning
confidence: 99%